[1]薛艳,安瑞芳.放射免疫显像在妇科肿瘤中的研究与应用[J].国际放射医学核医学杂志,2006,30(1):36-38.
 XUE Yan,AN Rui-fang.A research on radioimmunoimaging and its application in diagnosis of gynecological tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):36-38.
点击复制

放射免疫显像在妇科肿瘤中的研究与应用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
30
期数:
2006年第1期
页码:
36-38
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
A research on radioimmunoimaging and its application in diagnosis of gynecological tumors
作者:
薛艳 安瑞芳
710061 西安, 西安交通大学第一医院妇产科
Author(s):
XUE Yan AN Rui-fang
Department of Gynecology and Obstetrics, The First Hospital of Xian Jiaotong University, Xian 710061, China
关键词:
放射免疫检测卵巢肿瘤子宫内膜肿瘤宫颈肿瘤妊娠滋养细胞疾病
Keywords:
RadioimmunodetectionOvanan neoplasmsEndometrial neoplasmsCervix neoplasmsGestational trophoblastic disease
分类号:
R737.3;R817.4
摘要:
放射免疫显像是利用肿瘤相关单克隆抗体与肿瘤抗原特异性结合的原理,通过放射性浓集区强度的不同而显示出肿瘤病灶,故在肿瘤的诊断中发挥着重要的作用。本文综述近年来在妇科肿瘤中的研究与应用的进展。
Abstract:
Radioimmunodetection (RII) is the new diagnostic way combined immunology and radiology. It bases on the theory that tumor associated antigen can combine with antibody specially, and then show the tumor lesion position according to the different intensity of nucleus, so it plays an important role in the process of diagnosing tumour. In this article, reviewed the advancement of RII about the investigation and application in gynecological tumor.

参考文献/References:

1 Buchsbaum DJ.Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs.Semin Nucl Med,2004,34(1):32-46.
2 Dimitrov G,Iovchev I,Nikolov S.Radioimmunoguided surgery-a new stage of therapeutic management of oncological patients.Khirurgiia(Sofiia),2000,56(5-6):68-70.
3 Wan X,Zhang D,Yang X.Radioimmunodetection of human trophoblastic cancer xenograft in nude mice.Zhonghua Zhong Liu Za Zhi,1999,21(5):342-344.
4 Wan X,Yang X,Song H.Radioimmunodetection in the diagnosis of trophoblastic disease.Zhonghua Fu Chan Ke Za Zhi,1999,34(11):664-666.
5 Ozols RF,Rubin SC,Thomas GM,et al.Epithelial ovarian cancer.principles and practice of gynecologic oncology,Lippincot Williams and Wilkins,Philadephia,2000,981-1058.
6 Classe JM,Fontanelli R,Bischof-Delaloye A,et al.Ovarian cancer management.Practice guidelines for nuclear physicians.Q J Nucl Med Mol Imaging,2004,48(2):143-149.
7 Kalofonos HP,Karamouzis MV,Epenetos AA.Radioimmunoscintigraphy in patients with ovarian cancer.Acta Oncol,2001,40(5):549-557.
8 Magnani P,Fazio F,Grana C,et al.Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy.Br J Cancer,2000,82(3):616-620.
9 Lieberman G,Buscombe JR,Hilson AJ,et al.Preoperative diagnosis of ovarian carcinoma with a novel monoclonal antibody.Am J Obstet Gynecol,2000,183(3):534-540.
10 Pelosi E,Arena V,Baudino B,et al.Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer.Tumori,2002,88(3):S9-S10.
11 Yuan CC,Tsa LC,Shyong WY,et al.Radioimmunodetection of cervical carcinoma xenografts with (111)In-labeled MAb Cx-99detected by a hand-held gamma detector.Eur J Gynaecol Oncol,2002,23(3):178-182.
12 Chrastina A,Pastorekova S,Pastorek J.Immunotargeting of human cervical carcinoma xenografty expressing CA Ⅸ tumor-associated antigen by 125I-labeled M75 monoclonal antibody.Neoplasma,2003,50(1):13-21.

相似文献/References:

[1]孙昱,符达,刘兴党.卵巢癌循环肿瘤细胞的生物学特性及其临床应用进展[J].国际放射医学核医学杂志,2016,40(1):60.[doi:10.3760/cma.j.issn.1673-4114.2016.01.012]
 Sun Yu,Fu Da,Liu Xingdang.Progress in biological characteristics and clinical application of circulating tumor cells in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):60.[doi:10.3760/cma.j.issn.1673-4114.2016.01.012]
[2]王立凯,黄丽娟,潘学继,等.人附睾蛋白4单克隆抗体与免放试剂盒的制备及其对卵巢癌诊断的临床价值探讨[J].国际放射医学核医学杂志,2016,40(3):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
 Wang Likai,Huang Lijuan,Pan Xueji,et al.Preparation of monoclonal antibodies and immunoradiometric assay kit against human epididymis protein 4 and its clinical value in diagnosis of ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
[3]宋梦姣,韩栋梁,葛宁,等.放疗增敏研究中人卵巢癌SKOV3乏氧细胞模型的建立方法[J].国际放射医学核医学杂志,2014,38(6):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
 Song Meng-jiao,Han Dong-liang,Ge Ning,et al.The method of establishing the hypoxic SKOV3 cellular model in the research of radiotherapy sensitizer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
[4]李鹏,赵卫威,杨建伟.18F-FDG PET-CT在探测卵巢癌术后复发与转移中的应用价值[J].国际放射医学核医学杂志,2012,36(6):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
 LI Peng,ZHAO Wei-wei,YANG Jian-wei.18F-FDG PET-CT imaging in the detection of recurrent and metastasis ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
[5]尤徐阳,万卫星.放射免疫显像及其在胰腺癌研究中的应用[J].国际放射医学核医学杂志,2008,32(5):264.
 YOU Xu-yang,WAN Wei-xing.Radioimmunoimaging progress and its value of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):264.
[6]史文琴.PET显像在卵巢癌诊断中的作用[J].国际放射医学核医学杂志,2001,25(4):158.
 SHI Wen-qin.The application of 18F-FDG PET in diagnosing of ovarian carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):158.
[7]张伟,于丽娟.18F-FDG PET/CT与18F-FDG PET/MRI在卵巢癌临床应用中的进展[J].国际放射医学核医学杂志,2018,(5):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]
 Zhang Wei,Yu Lijuan.Advances in clinical application of 18F-FDG PET/CT and 18F-FDG PET/MRI in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]

备注/Memo

备注/Memo:
收稿日期:2005-03-28。
通讯作者:安瑞芳(E-mail:anruifang@163.com)
更新日期/Last Update: 1900-01-01